Skip Navigation

Cardiovascular Research 1999 44(2):247-248; doi:10.1016/S0008-6363(99)00243-6
© 1999 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by van der Laarse, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Laarse, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1999, European Society of Cardiology

Rapid estimation of myocardial infarct size

Arnoud van der Laarse

Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands

Received 30 July 1999; accepted 2 August 1999

The first 10% of the full text of this article appears below.

See article by de Groot et al. [9] (pages 315–324) in this issue.

Although the use of biochemical markers of acute myocardial infarction started in 1954 [1], their value in estimating myocardial infarct size was demonstrated roughly 20 years later. The groups of Hermens and colleagues [2] and Sobel and colleagues [3] independently reported methods to calculate infarct size on the basis of serial serum enzyme activities, such as creatine kinase (CK) and {alpha}-hydroxybutyrate dehydrogenase ({alpha}HBDH). The . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?